Skip to main content
Caplight Logo









Spiro Medical, Inc.

Spiro Medical, Inc.

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.spiromedical.com/

Last Round

Series A

Jan 7, 2026

Total Funding Raised

$67M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Spiro Medical, Inc. is a medical technology company developing an implantable pulmonary neuromodulation system for the treatment of severe, uncontrolled asthma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

obstructive sleep apneaOSAmedical deviceminimally invasive surgeryneuromodulationsleep apnea treatmentCPAP alternativeimplantable deviceENTotolaryngologysleep medicineairway obstructionmedtechsleep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spiro Medical, Inc. Comparables

Compare Spiro Medical, Inc. with similar companies based on industry and business-model similarity.

Spiro Medical, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LinguaFlex, Inc.
85%
XII Medical
83%
Cryosa
78%

Spiro Medical, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 7, 2026

Spiro Medical, Inc. Investors

Notable investors and investment history

Spiro Medical, Inc. investors
InvestorRounds
Omega FundsSeries A
Andera PartnersSeries A
Northern Light Venture CapitalSeries A
Supernova InvestSeries A
Hero EnterpriseSeries A
Sherpa Healthcare PartnersSeries A
HongShan Capital Group (HSG)Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2026

    $67M round led by Andera Partners, Omega Funds, and Sherpa Healthcare Partners.

Spiro Medical, Inc. Filings

Explore SEC and related filing metadata, where available.

Spiro Medical, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spiro Medical, Inc.'s valuation, stock price, and market status.

Is Spiro Medical, Inc. a public or private company?

Spiro Medical, Inc. is a private company.

What is the current stock price of Spiro Medical, Inc.?

Spiro Medical, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Spiro Medical, Inc. worth (valuation)?

Valuation information for Spiro Medical, Inc. is not publicly available.

Can I buy Spiro Medical, Inc. stock?

Spiro Medical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spiro Medical, Inc.'s last funding round?

Spiro Medical, Inc.'s most recent funding round was Series A on January 7, 2026.

Who are the main investors in Spiro Medical, Inc.?

Key investors in Spiro Medical, Inc. include Omega Funds, Andera Partners, Sherpa Healthcare Partners.

Will Spiro Medical, Inc. IPO soon?

No public IPO plans have been announced for Spiro Medical, Inc..

How can I track Spiro Medical, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spiro Medical, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Year Founded2023
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?